… Treatment with ursodeoxycholic acid renders children with … Ursodeoxycholic acid therapy
in the treatment of biliary … Ursodeoxycholic acid treatment produces marked clinical and …

… study comparing ursodeoxycholic acid with placebo for the prevention of acute cellular
rejection after … Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver …

… of UDCA necessary to prevent episodes of the incidence of rejection was found, this study
does show of acute rejection or steroid-resistant rejection is not known; that the addition of …

… chronic rejection. Two patients in the UDCA group received two grafts, one at 43 days for
acute rejection that did not respond to OKT3 and another at 11 months for chronic rejection; …

… Acute rejection is reported to occur in 50-70% of patients receiving liver transplants. … , acute
rejection is still a major problem in liver transplant surgery [3, 9, 10, 21]. Ursodeoxycholic acid …

… ursodeoxycholic acid (UDCA) for liver-transplant recipients has been reported to reduce the
frequency of acute rejection … and increase the amount of transplant tolerance in rats. Serum …

… Ursodeoxycholic acid for prevention of acute rejection in liver transplant recipients. Lancet
1990;336:52-… Adjuvant treatment with ursodeoxycholic acid reduces acute rejection after liver …

… were used: ursodeoxycholic acid, ursodiol, bile acids and/or … , liver transplant, liver graft,
transplant rejection, graft rejection, … Rates of acute rejection were not different for bile acids- …

… In this study we report a reduced frequency of acute rejection in 41 consecutive liver
transplant recipients treated with adjuvant UDCA compared to the numbers given in the literature …

… Ursodeoxycholic acid (UDCA) is a hydrophilic bile acid known to have … of transplant rejection
( 6–8 ). UDCA has also been shown to reduce the incidence and severity of acute rejection …